Sherlock Biosciences Inc. plans to start commercializing its CRISPR-based Covid-19 tests next year — if there's still a market for them. Sherlock Biosciences Inc. plans to start commercializing its ...

Sherlock Biosciences received the first FDA emergency authorization for a CRISPR-based Covid-19 test, a 2020 milestone that showed the technology can work in diagnostics. But it didn’t save time.

Steven Weintraub launched Collider in the summer of 2005. As Editor-in-chief, he has taken the site from a small bedroom operation to having millions of readers around the world. Over the years, he ...

Senior Editor - Games | Former Editor of Animation, Streaming Content |Author of "The Science of Breaking Bad" from MIT Press | Twitch Affiliate: twitch.tv/drclawmd | Co-host of the Saturday Mourning ...

The 1,300-word story is titled Sherlock Homes: Discovering the Border Burghs and, by deduction, the Brig Bazaar, and was published in a 48-page booklet to raise money for a local bridge to be built in ...

BOSTON, March 8, 2022 /PRNewswire/ -- Sherlock Biosciences, a company engineering biology to bring next-generation diagnostics to the point-of-need, today announced it has raised $80 million in a ...